Search

MSK investigators have used a lab tool originally developed to study fly nerve cells to uncover new findings about acute myeloid leukemia.

… Monday, April 27, 2020 Summary MSK investigators have used a lab tool originally developed to study fly nerve cells to study RNA-binding proteins in blood cells from mammals. The technique has allowed them to uncover new clues about acute myeloid leukemia. If you think of cells as factories for making

Read the inspiring story of two MSK employees, Jennifer Brosnan and Santosha Vardhana, and why they lead Cycle For Survival teams to raise money to support research into rare cancers.

… Monday, June 10, 2024 Even when they’re off the clock, the people of MSK devote themselves to raising money for cancer research through events like Cycle for Survival® , MSK’s biggest fundraising event of the year, focused on conquering rare cancers. These are just two of the people who epitomize the

New MSK research sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of glioma-associated macrophages that appear to play a pivotal role in progression; and demonstrates that reduced surgery is an option for some thyroid cancer patients.

… Tuesday, January 20, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of glioma-associated macrophages that appear to play a pivotal role in progression; and demonstrates that reduced surgery

Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

… Monday, December 22, 2008 Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic. Highly sensitive and specific probes and molecular

Diagnosed with ovarian cancer at 51, Pauline Larkin feared her racing days were over — within the year, she was running in the NYC marathon with her MSK doctors by her side.

… Thursday, April 10, 2025 When 51-year-old Pauline Larkin was diagnosed with ovarian cancer in January 2024, she wasn’t sure she would ever lace up her running shoes again. It all started a few days after finishing the 2023 TCS New York City Marathon , when she felt cramps and bloating. Maybe she went

Two encouraging Memorial Sloan Kettering Cancer Center (MSK) studies were featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program.

… Tuesday, April 21, 2015 Two encouraging Memorial Sloan Kettering Cancer Center (MSK) studies were featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research

Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.

… Thursday, August 7, 2014 Summary Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will. Memorial Sloan Kettering researchers have pioneered a new method to study complex genetic conditions including cancers

Our findings indicate that surgical site infections can be reduced effectively over the long term with a hospital-wide implementation of multidisciplinary best practices.

… Thursday, December 13, 2018 Implementation of a multidisciplinary care bundle composed of 13 perioperative components has significantly decreased the rate of surgical site infections (SSIs) among patients undergoing colorectal cancer surgery at Memorial Sloan Kettering Cancer Center, according to our

The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.

… Tuesday, September 7, 2021 Memorial Sloan Kettering Cancer Center has received a major grant from the US National Institutes of Health (NIH) to conduct research related to leukemia . It is the sixth grant of this type to be received by MSK investigators. It is referred to as a SPORE grant, for Specialized

Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS, has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK).

… Thursday, July 12, 2018 Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS , has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician and leader, Dr. Gerstle most recently served as Director of